# Notch Signaling Exacerbates Pulmonary Fibrosis by Regulating the Differentiation of CD4+ Tissue-Resident Memory T Cells

**Authors:** Jia Shi, Ruiting Su, Lili Zhuang, Zhangmei Lin, Xinyuan Ruan, Yichao Qian, Jieying Zhu, Shuyi Wang, Niansheng Yang

PMC · DOI: 10.3390/biom16020328 · Biomolecules · 2026-02-20

## TL;DR

CD4+ tissue-resident memory T cells worsen lung fibrosis by promoting inflammation, and their differentiation is regulated by the Notch signaling pathway.

## Contribution

Identifies CD4+ TRM cells as pathogenic drivers in pulmonary fibrosis and reveals Notch signaling as a key regulator of their differentiation.

## Key findings

- CD4+ TRM cells are present in higher numbers in fibrotic lungs and correlate with disease severity.
- Depletion of CD4+ TRM cells reduces fibrosis in mouse models.
- Notch signaling inhibition suppresses pro-fibrotic functions of CD4+ TRM cells.

## Abstract

The involvement of the immune system in pulmonary fibrosis is established, the precise contributions of tissue-resident memory T (TRM) cells are still poorly defined. This study sought to define the contribution of CD4+ TRM cells to pulmonary fibrosis, their origin, and regulatory mechanisms. We combined bioinformatic analysis of human fibrotic lung single-cell RNA-sequencing data with experiments in a bleomycin-induced C57BL/6 mouse model. Flow cytometry, targeted in vivo depletion, lymphocyte trafficking blockade, cell co-culture, and pharmacological inhibition were employed. CD4+ TRM cells were observed at higher frequencies within fibrotic lung tissue. Their presence correlated with disease severity, and they were found to exhibit a pro-inflammatory and pro-fibrotic phenotype. Their specific depletion alleviated fibrosis. These cells primarily originated from recruited circulating lymphocytes, as blocking this recruitment reduced TRM accumulation and attenuated disease. Furthermore, the Notch signaling pathway was activated in fibrotic lung CD4+ TRM cells, and its inhibition suppressed their differentiation and impaired their pro-fibrotic function. We conclude that CD4+ TRM cells are pathogenic drivers in pulmonary fibrosis, originating from circulating precursors and being regulated by Notch signaling, underscoring their relevance for therapeutic intervention.

## Linked entities

- **Proteins:** Notch (neurogenic locus notch homolog)
- **Diseases:** pulmonary fibrosis (MONDO:0002771)

## Full-text entities

- **Genes:** CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, Cd28 (CD28 antigen) [NCBI Gene 12487], trm (tremor) [NCBI Gene 22052], Ccr7 (C-C motif chemokine receptor 7) [NCBI Gene 12775] {aka CC-CKR-7, CCR-7, CD197, Cdw197, Cmkbr7, EBI1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439] {aka P2X(7), P2X7R}, ZNF683 (zinc finger protein 683) [NCBI Gene 257101] {aka Hobit}, SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, Notch1 (notch 1) [NCBI Gene 18128] {aka 9930111A19Rik, Mis6, N1, Tan1, lin-12}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, DLL1 (delta like canonical Notch ligand 1) [NCBI Gene 28514] {aka DELTA1, DL1, Delta, NEDBAS}, JAG2 (jagged canonical Notch ligand 2) [NCBI Gene 3714] {aka HJ2, LGMDR27, SER2}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, Fasl (Fas ligand) [NCBI Gene 14103] {aka APT1LG1, CD178, CD95-L, CD95L, Fas-L, Faslg}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, DLL3 (delta like canonical Notch ligand 3) [NCBI Gene 10683] {aka SCDO1}, ITGA1 (integrin subunit alpha 1) [NCBI Gene 3672] {aka CD49a, VLA1}, Itgae (integrin alpha E, epithelial-associated) [NCBI Gene 16407] {aka A530055J10, CD103, aM290, alpha-E1, alpha-M290}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, JAG1 (jagged canonical Notch ligand 1) [NCBI Gene 182] {aka AGS, AGS1, AHD, AWS, CD339, CMT2HH}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, S1pr1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 13609] {aka Edg1, Lpb1, S1p, S1p1}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, Gzma (granzyme A) [NCBI Gene 14938] {aka Ctla-3, Ctla3, Hf, Hf1, SE1, TSP-1}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, Prdm1 (PR domain containing 1, with ZNF domain) [NCBI Gene 12142] {aka Blimp-1, Blimp1, PRDI-BF1, ZNFPR1A1, b2b1765Clo}, ITGAE (integrin subunit alpha E) [NCBI Gene 3682] {aka CD103, HUMINAE}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}
- **Diseases:** overdose (MESH:D062787), inflammatory bowel disease (MESH:D015212), PF (MESH:D011658), CTD-ILD (MESH:D017563), IPF (MESH:D054990), mucosal infections (MESH:D007239), weight loss (MESH:D015431), cytotoxic (MESH:D064420), death (MESH:D003643), pulmonary dysfunction (MESH:D011660), fibrotic damage (MESH:D020263), HP (MESH:D000542), hemorrhage (MESH:D006470), fibrotic lesions (MESH:D009059), pulmonary inflammatory (MESH:D016726), Fibrotic Lungs (MESH:D008171), lung injury (MESH:D055370), asthma (MESH:D001249), impaired daily functioning (MESH:D020773), pulmonary edema (MESH:D011654), deterioration of pulmonary function (MESH:D055371), Fibrosis (MESH:D005355), Inflammatory (MESH:D007249), injury to (MESH:D014947)
- **Chemicals:** DAB (MESH:C000469), alcohol (MESH:D000438), PBS (MESH:D007854), NAD+ (MESH:D009243), eosin (MESH:D004801), L-glutamine (MESH:D005973), 2-mercaptoethanol (MESH:D008623), H&amp;E (MESH:D006371), hydrogen peroxide (MESH:D006861), DAPT (-), Hematoxylin (MESH:D006416), ionomycin (MESH:D015759), penicillin (MESH:D010406), K+ (MESH:D011188), FTY720 (MESH:D000068876), BLM (MESH:D001761), TRIzol (MESH:C411644), sodium pentobarbital (MESH:D010424), streptomycin (MESH:D013307), Paraffin (MESH:D010232), brefeldin A (MESH:D020126)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937952/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937952/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937952/full.md

---
Source: https://tomesphere.com/paper/PMC12937952